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Tumour Necrosis Factor (TNF) is critical for host control of M. tuberculosis, but the relative contribution of
TNF from innate and adaptive immune responses during tuberculosis infection is unclear. Myeloid versus
T-cell-derived TNF function in tuberculosis was investigated using cell type-specific TNF deletion. Mice
deficient for TNF expression in macrophages/neutrophils displayed early, transient susceptibility to M.
tuberculosis but recruited activated, TNF-producing CD41 and CD81 T-cells and controlled chronic
infection. Strikingly, deficient TNF expression in T-cells resulted in early control but susceptibility and
eventual mortality during chronic infection with increased pulmonary pathology. TNF inactivation in both
myeloid and T-cells rendered mice critically susceptible to infection with a phenotype resembling complete
TNF deficient mice, indicating that myeloid and T-cells are the primary TNF sources collaborating for host
control of tuberculosis. Thus, while TNF from myeloid cells mediates early immune function, T-cell derived
TNF is essential to sustain protection during chronic tuberculosis infection.
I
nitial events during pulmonary M. tuberculosis infection involve binding and uptake of M. tuberculosis by
alveolar macrophages. Subsequent immune responses are therefore dependent on initial activation of infected
macrophages through, amongst others, induction of appropriate activating molecules, production of cytokines
and chemokines and synthesis of bactericidal molecules. In vitro studies have shown that macrophage stimulation
through M. tuberculosis or mycobacterial antigens results in secretion of TNF which is a requirement for
induction of cell activation1–4. However, coactivation by IFNc is required for full bactericidal status and inhibition
of mycobacterial growth2,5. In vivo challenge studies confirmed TNF as an integral component of the host immune
defence mechanism against mycobacterial infection that promotes the initiation and maintenance of granulomas
during infection6–9. Among other family members, such as lymphotoxin (LT) a, LTb, FasL, CD40L, RANKL,
CD27L and OX40L10, TNF mediated protection is non-redundant despite the potential of soluble LTa to also bind
and signal through both TNF receptors11,12. TNFRp55 is thought to be primarily responsible for mediating most
TNF mediated effects13,14. TNF signalling can induce cell death, promote cell survival and induce proinflamma-
tory responses under defined cellular and micro-environmental conditions14. Both 26 kd membrane-anchored
and 17 kD soluble TNF forms15,16 contribute to the control of M. tuberculosis infection17–19. TNF is produced by
multiple cell types including macrophages, neutrophils, dendritic cells, lymphocytes and NK cells as well as by
cells of non-hematopoietic origin20. However, the precise role of TNF derived from these cells in infection remains
unclear and requires investigation. The clinical importance of TNF to control mycobacterial replication was
demonstrated during anti-TNF treatment of patients with rheumatoid arthritis, Crohn’s disease or severe psori-
asis, where, in some cases, patients developed spontaneous tuberculosis reactivation21,22. T cells and macrophages
are crucial components of protective granulomas and are potentially relevant sources of TNF in vivo, responding
to antigens or to microbial components, respectively23,24. We reported earlier that TNF derived from hemato-
poietic cells is essential to control mycobacterial BCG infection9. Further, cell transfer experiments suggest that
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important to define the contribution and kinetics of the TNF res-
ponses issued from adaptive, T lymphocytes versus innate pha-
gocytic, macrophage/neutrophils, in the control of acute and
chronic M. tuberculosis infection.
In this study we examined the role of TNF produced by
macrophages and neutrophils, or by T-cells, using cell-specific gene-
inactivated mice26 in M. tuberculosis infection models. We dem-
onstrate the significance of myeloid, macrophage/neutrophil derived
TNF for protective immune responses during early M. tuberculosis
infection. This function becomes redundant during persistent infec-
tion, while T-cell derived TNF is essential for long-term control of
chronic infection in a non-redundant fashion. Therefore, two major
cellular sources of TNF in protection against mycobacteria display
both redundant/overlapping and non-redundant/specific functions.
Results
TNF produced by myeloid cells is required for control of pulmo-
nary M. tuberculosis replication during acute, but not persistent,
infection. To address whether TNF derived from macrophages/
neutrophils is required for protective immune functions in vivo, we
first investigated disease outcome in M-TNF2/2 mice during in-
fection with virulent M. tuberculosis in comparison with either
immune-competent WT mice or complete TNF deficient mice.
The inability to produce any TNF rendered mice highly susceptible
to M. tuberculosis aerosol inhalation challenge resulting in rapid
weight loss (Fig. 1A) and death within 42 days (Fig. 1B), con-
firming previous reports6,18. Strikingly, both WT- and M-TNF2/2
mice were resistant to infection without notable loss of bodyweight
(Fig. 1A) and survived the 7 month duration of the experiment
(Fig. 1B). Thus quite unexpectedly, survival of M-TNF2/2 mice
clearly indicated that macrophages and neutrophils were not the
unique, essential sources of TNF to elicit a sustained protective
response to M. tuberculosis.
Several studies have correlated uncontrolled mycobacterial rep-
lication with high susceptibility in TNF2/2 mice6,9,27. Our working
hypothesis was that M. tuberculosis recognition may lead to subop-
timal macrophage activation in the absence of TNF synthesis in M-
TNF2/2 mice, resulting in possible susceptibility due to a reduced
capability to restrict bacterial replication during early infection. The
resistant phenotype of M-TNF2/2 mice was unexpected since TNF is
required for optimum activation of infected macrophages to restrict
M. tuberculosis growth2,28–30. We thus investigated the effect of TNF
produced by myeloid cells on bacterial replication by comparing
pulmonary bacilli growth in WT-, M-TNF2/2- and TNF2/2 mice
over a period of 7 months after M. tuberculosis challenge. Interes-
tingly, M-TNF2/2 mice failed to control pulmonary bacilli replica-
tion within the first 3–4 weeks of infection and developed high bacilli
titers similar to TNF2/2 mice which were 1–2 log10 higher than WT
mice (Fig. 1C). Ziehl-Neelsen staining of infected lung tissue con-
firmed distinctive differences in bacilli loads in the respective geno-
types (Fig. 1D). However, the susceptibility of M-TNF2/2 mice was
transient and the high pulmonary bacilli burden was eventually
reduced to levels similar to that of WT mice during persistent in-
fection, whereas in TNF2/2 mice bacilli replication remained unres-
tricted. Thus, the absence of TNF production by macrophages/
neutrophils was clearly associated with defective control of bacilli
growth during early infection, but it could be compensated for
thereafter.
Considering earlier reports on TNF dependent restriction of M.
tuberculosis replication we wanted to confirm that early susceptibility
of M-TNF2/2 was indeed a function of deficient TNF synthesis and
bacterial control by macrophages from these mice31–33. TNF release
by macrophages occurs upon infection or exposure to various stim-
uli29,34,35. WT macrophages released TNF after infection with M.
tuberculosis H37Rv (Fig. 1E), and the growth of the bacilli was
restrained, as seen with the luminescent, luciferase expressing
reporter M. tuberculosis H37Rv strain (Fig. 1F). In contrast, in
macrophages from TNF2/2 mice, the absence of TNF release, was
accompanied by failure to restrain the bacilli growth. We dem-
onstrate here that infected macrophages derived from M-TNF2/2
mice that fail to produce TNF as shown earlier36 are defective in
controlling bacteria growth, similar to macrophages from TNF2/2
mice. Therefore, our data clearly supports the importance of TNF,
and in particular macrophage-derived TNF, in controlling mycobac-
terial replication.
TNF produced by myeloid cells regulates lung inflammation but is
not required for the initiation and maintenance of granuloma
structural integrity. It is well established that containment and
control of bacilli growth is dependent on the establishment of
functional, bactericidal granulomas. In view of uncontrolled M.
tuberculosis replication during early infection in M-TNF2/2 mice,
we expected that the establishment of granulomas would be
defective in the absence of TNF synthesis by macrophages and
neutrophils. TNF is required not only for the initiation, but also
for maintenance of granulomas and we and others have previously
reported the lack of granuloma formation in the absence of TNF after
mycobacterial challenge6–9. However, granulomas comprise different
cell types, many capable of synthesising TNF that could potentially
contribute to their structural integrity. To gain further insight into
the transient nature of the immune response in M-TNF2/2 mice, we
investigated whether macrophages and neutrophils were an essential
cellular source of TNF during the establishment of granulomas. As a
correlate for infection-induced inflammation we measured lung
weights (Fig. 2A) and found a transient increase of lung weights in
M-TNF2/2 mice which peaked at day 28 post infection, with partial
resolution after day 35 post infection. In contrast, sustained,
uncontrolled inflammation was observed in TNF2/2 mice, at
significantly higher levels than in either M-TNF2/2 or WT mice on
day 35 post infection, when TNF2/2 mice succumbed to infection.
Controlled inflammation in M-TNF2/2 mice was substantiated by
quantitative assessment of pulmonary infiltrating leukocytes
(Fig. 2B) which was significantly higher compared to WT mice,
while TNF2/2 mice experienced a delay in cell recruitment at
day 21 followed by excessive cell infiltration in the lung 35 days
post-infection.
We further assessed the role of macrophage and neutrophil
derived TNF for structural granuloma integrity during M. tuber-
culosis challenge. Macroscopic lung pathology showed no distinction
amongst the strains after 21 days of infection (Suppl. Fig. 1), but
differences were clearly evident at 28 days post-infection (Fig. 2C).
Small, defined lesions were present on the pleura of WT mice while
TNF2/2 mice had large and in part confluent nodules. Interestingly,
M-TNF2/2 mice presented with an intermediate lesion phenotype
not as severe as observed in TNF2/2 mice but not as small and
compact as in WT mice (Fig. 2C). Histological assessment showed
that, although enlarged, pulmonary granulomas in M-TNF2/2 mice
were well structured with no necrotic areas, in contrast to TNF2/2
mice which displayed effaced structures with necrotic centers on day
28 post infection (Fig. 2D). Importantly, the kinetics of granuloma
formation was normal in M-TNF2/2 mice with no evidence of a delay
in the onset of granuloma initiation (data not shown) as previously
reported for TNF2/2 mice6. Examination of tissues at higher mag-
nification clearly showed occlusion of bronchi and blood vessels in
TNF2/2 mice but not in M-TNF2/2 - or WT mice. Moreover, the
differences noted in pulmonary pathology between WT and M-
TNF2/2 mice during early stages of infection were transient and
clearly absent during chronic infection (Fig. 2Dii). At six months
post-infection lung sections were pathologically indistinguishable,
with defined structural granulomas present and no necrosis was
evident in either M-TNF2/2- or WT mice (Fig. 2Dii). Therefore,
TNF produced by myeloid cells regulates inflammation and cellular
www.nature.com/scientificreports
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Figure 1 | TNF from myeloid cells is required to control acute M. tuberculosis replication in vivo. (A–D) WT (closed circle), M-TNF2/2 (grey triangle)
and TNF2/2 (open circle) mice were infected by aerosol inhalation with 200–500 cfu/lung of M. tuberculosis H37Rv and body weight changes (A) and
mortality (B) (n 5 10 mice/group) were monitored. Changes in bodyweight values are expressed as the mean of 4–10 mice/group. Data represents one of
three independent experiments. The number of viable bacteria present in lungs was assessed at the indicated time points (C). The results are expressed as
the mean 6 SD of 5 mice/group per time point and represent one of three independent experiments. * 5 p , 0.05 (WT versus M-TNF2/2 mice),
# 5 p , 0.05 (WT versus TNF2/2 mice.),w5 p , 0.05 (M-TNF2/2 versus TNF2/2 mice). Ziehl-Neelsen staining of lungs at 35 days post infection (D). The
results represent one of four similar experiments. (Magnification 5 6003). Arrows indicate the presence of AFB. (E) WT (black), M-TNF2/2 (grey) and
TNF2/2 (clear) bone marrow derived macrophages were stimulated either with LPS (100 ng/ml) or M. tuberculosis H37Rv (at a MOI of 251) for 48 hrs
and TNF measured by ELISA. The results are expressed as the mean 6 SD of quadruplicate values and are representative of one of three independent
experiments. ND: Not detected. (F) Bone marrow derived macrophages were infected with M. tuberculosis expressing luciferase and bacterial replication
measured as relative luminescence after 100 hrs. The results are expressed as the mean 6 SD of quadruplicate values and represent one of three
independent experiments.
www.nature.com/scientificreports
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Figure 2 | TNF from myeloid cells regulates cellular recruitment for granuloma formation but is dispensable for initiation and maintenance of
granuloma structure. (A; B) WT (black), M-TNF2/2 (grey), and TNF2/2 (clear) mice were infected with M. tuberculosis H37Rv as described under
‘‘Materials and Methods’’ and lung weights (A) and cell numbers (B) assessed at the indicated time points. Data represent the mean 6 SD of 5 mice per
time point and one of three independent experiments. *5 p , 0.05 (WT versus M-TNF2/2 mice), # 5 p , 0.05 (WT versus TNF2/2 mice.), w5 p , 0.05
(M-TNF2/2 versus TNF2/2 mice). (C–D). Macroscopic lung pathology (C) in WT, M-TNF2/2 and TNF2/2 mice at 28 days post infection (one of three
independent experiments; n 5 5 mice/strain). Low magnification (203) of pulmonary granulomas at (i) 28 days and (ii) 166 days postinfection after
haemotoxylin and eosin staining (D). Arrows indicate granulomatous structures and X indicates necrosis. The results represent one of 5 similar
experiments.
www.nature.com/scientificreports
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recruitment to the lung but is not required for initiating and main-
taining the structural integrity of granulomas.
TNF produced by myeloid cells regulates pulmonary lymphocytic
recruitment during early M. tuberculosis infection. Protective
immunity in response to M. tuberculosis is cell-mediated37,38 and
the recruitment of T cells, especially CD41- and CD81 T cells, is
critical to control the growth of bacilli39,40. TNF is an important
mediator of cellular traffic through the regulation of adhesion
molecule expression, dendritic cell maturation and chemokine
induction27,41. To understand the mechanism responsible for the
transient nature of susceptibility in M-TNF2/2 mice, we asked
whether lymphocytic recruitment and activation were affected by
the lack of macrophage/neutrophil derived TNF. Here, we first
measured migration of lymphocytes to local sites of infection and
found that M-TNF2/2 mice had a small but significantly higher
recruitment of both CD41 (Fig. 3A) and CD81 (Fig. 3B) T cells to
the lung at 21 and 28 days post infection as compared to WT mice.
Enhanced lymphocytic recruitment in M-TNF2/2 mice was
transitory and levels similar to those in WT mice were recorded at
35 days post infection. Conversely, TNF2/2 mice seemed to control
cell migration during the early stages of infection, but 2–4-fold
increased CD41 and CD81 T cell levels were measured on day 35,
correlating with the overwhelming bacilli burden at this latter stage
of infection. The transient increase in pulmonary CD41 and CD81 T
cells seen during early infection in M-TNF2/2 mice was effectively
controlled thereafter, suggesting that the control of excessive lym-
phocytic response was independent of macrophage/neutrophil
derived TNF but likely dependent upon another source of TNF
like T-cell derived TNF. We further assessed the activation status
of the lung infiltrating CD41- and CD81 T cell subsets by flow
cytometry for expression of the leukocyte homing and activation
marker CD44 (Fig. 3C and 3D) and the early activation marker
CD69 (Fig. 3E and 3F). CD41- and CD81 T cells recruited to the
lung after M. tuberculosis infection expressed CD44 and CD69 in all
the respective strains. Thus, the absence of TNF production by
myeloid cells favoured early recruitment of CD41 and CD81 acti-
vated T cells to the lung in response to M. tuberculosis infection.
M. tuberculosis specific T cell-priming is independent of TNF
produced by myeloid cells. Resistance to M. tuberculosis is highly
dependent on the host’s capability to induce an effective Th1
immune response40,42,43. Our studies indicated a down-regulation of
CD41- and CD81 T cell recruitment by TNF synthesized by myeloid
cells with no clear effect on lymphocyte activation. To further assess
how distinct cellular sources of TNF may affect Th1 immune
function we next investigated IFNc release by primed CD41- and
CD81 T cells in response to mycobacterial antigens in M-TNF2/2
mice. Single cell suspensions from lungs harvested at 21 day post M.
tuberculosis infection were restimulated ex vivo with purified protein
derivative (PPD), early secreted antigen of 6 kDa (ESAT-6), or anti-
CD3/anti-CD28 antibodies. Restimulation of lung infiltrating CD41
T cells from TNF2/2 mice showed compromised IFNc expression in
response to ESAT-6, PPD or anti CD3/CD28 antibodies, to only one
third of that seen in WT cells, while cells from M-TNF2/2 mice had a
2-fold increased IFNc response (Fig. 4A(i and ii)). We found no
differences in IFNc synthesis of restimulated CD8 T cells amongst
the mutant and control strains (data not shown). Moreover, the level
of IFNc in whole lung homogenates was increased in M-TNF2/2
mice at 21 days post-infection and contracted thereafter to con-
centrations equivalent to WT mice, while pulmonary IFNc in
TNF2/2 mice were equivalent to WT mice during the first 3 weeks
and highly increased at 4 weeks (Fig. 4B) Effective control of M.
tuberculosis infection is only possible when IL-12 synergizes with
IFNc to induce a Th1 immune response28,44. Pulmonary IL-12p70
levels increased strongly between 2 and 3 weeks post-infection in
both WT and M-TNF2/2 mice but were halved in TNF2/2 mice
(Fig. 4C). Therefore, the absence of TNF production by myeloid
cells did not compromise M. tuberculosis specific priming and
restimulation of lung infiltrating CD41 T cells.
TNF release by lung infiltrating CD41- and CD81 T cells during
M. tuberculosis infection is not compromised by the absence of
TNF from myeloid origin. The overall protection against M.
tuberculosis infection seen in M-TNF2/2 mice indicated that TNF
derived from an alternative cellular source, other than macrophages/
neutrophils contributed to protective immune functions. We thus
next addressed the contribution of T cells, a major cellular com-
ponent of bactericidal granuloma, as a source of TNF during
M. tuberculosis infection that could contribute to control bacilli
replication. Adoptive transfer experiments previously illustrated
that TNF secretion by lymphocytes is protective against M. tuber-
culosis challenge25. Moreover, it is known that T cells produce TNF
upon antigen specific activation and the addition of CD41 T cells to
M. tuberculosis infected monocytes enhances TNF production by
both T cells and monocytes45. We first investigated whether T cells
do respond to M. tuberculosis challenge by expressing TNF in vivo
and how this may be influenced by the absence of TNF from myeloid
origin. TNF expression by CD41- or CD81 T cells isolated from M.
tuberculosis infected WT mice 21 days post-infection was analyzed
Figure 3 | Transiently enhanced pulmonary infiltration of CD41 and
CD81 activated T cells is independent of TNF produced by myeloid cells
during M. tuberculosis infection. WT (black), M-TNF2/2 (grey) and
TNF2/2 (clear) mice were infected via aerosol inhalation with 200–500
cfu/lung of Mycobacterium tuberculosis. Lung cell suspensions from
infected mice were analyzed by flow cytometry to determine (A)
CD31CD41 and (B) CD31CD81 T cell pulmonary populations at day 21,
28 and 35 post-infection and activation status analysed for markers CD44
(C and D) and CD69 (E and F) on CD41 (C, E) and CD81 (D, F) T cells by
flow cytometry. The results are expressed as the mean 6 SD of 5 mice per
group and are from one experiment, representative of two independent
experiments.
www.nature.com/scientificreports
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Figure 4 | Enhanced M. tuberculosis specific priming of pulmonary CD41 T cells in infected M-TNF2/2 mice. (A) Lung cell suspensions from
M. tuberculosis H37Rv infected WT, M-TNF2/2 , and TNF2/2 mice harvested at 21 days post infection were restimulated with ESAT 6, PPD or antibodies
to CD3 and CD28 for 72 hrs and intracellular IFNc produced by CD41T cells assessed by flow cytometry. Fig. 4A(i) are representative dot blots of single
mice while the results in Fig. 4A(ii) are expressed as the mean 6 SD of 4 mice per group and represent one of two similar experiments. (B, C) Lung
concentrations of IFNc (B) and IL-12p70 (C) were determined by ELISA in lung homogenates of M. tuberculosis H37Rv infected WT (black), M-TNF2/2
(grey) and TNF2/2 (open) mice at different time points. The data are expressed as the mean and 6 SD of 4 mice/group for each time point and represent
one of two similar experiments.
www.nature.com/scientificreports
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by flow cytometry. TNF production was absent in CD41 T cells
isolated from TNF2/2 mice, as expected, while it was present or
slightly increased in CD41 or CD81 T cells isolated from M-
TNF2/2 mice (Supplementary Fig. 2). Therefore, T cell derived
TNF may compensate for the lack of TNF production by myeloid
cells in vivo during M. tuberculosis infection.
T cell derived TNF is required for sustained control of pulmonary
M. tuberculosis during chronic infection. Guided by our hypothesis
that CD41- and CD81 T cell derived TNF may compensate for the
absence of TNF produced by myeloid cells during early infection, we
next addressed the specific role of T-cell derived TNF in protective
immunity to M. tuberculosis and disease outcome. T cell specific
TNF2/2 (T-TNF2/2) mice26 were infected with M. tuberculosis and
the absence of TNF release by CD41 or CD81 T cells verified on day
21 post-infection (Suppl. Fig. 2). Strikingly, while WT mice survived
M. tuberculosis infection with no apparent loss of body mass and
TNF2/2 mice succumbed within 40 days with rapid bodyweight loss
(Fig. 5A, B), T-TNF2/2 mice survived significantly longer than
TNF2/2 mice, but eventually succumbed between 130–150 days
post-infection accompanied by severe loss of body mass (Fig. 5A,
B). Thus, ablation of TNF production by both CD41- and CD81 T
cells led to an inability of the host to sustain immune protection
during chronic M. tuberculosis infection.
We next investigated whether T cell derived TNF was implicated
in the control of M. tuberculosis replication during the generation of
protective immune responses. Pulmonary bacilli burden measured in
T-TNF2/2 mice on day 33 post-infection was similar to that seen in
WT mice, ca 5 log10 cfu per lung, in contrast to the 102–103 fold
higher bacterial loads of TNF2/2 mice (Fig. 5C). This indicated an
efficient early control of bacilli replication, independent of T cell
derived TNF during acute infection. Indeed, there was no significant
alteration of overall pulmonary TNF mRNA and protein expression
in cell-specific M-TNF2/2- or T-TNF2/2 mice, as compared to WT
mice, 4 weeks post M. tuberculosis infection (Suppl. Figure 3).
Considering mortality of T-TNF2/2 mice at 150 days post-infection
we evaluated bacilli burden during chronic infection (Fig. 5D).
Pulmonary bacterial burden was 10-fold higher in T-TNF2/2 mice
compared to WT control animals suggesting an importance of T cell
derived TNF for inhibiting pulmonary bacterial replication during
persistent/chronic infection (Fig. 5D). Thus, although TNF is pro-
duced by many cell types, T cell derived TNF has a non-redundant
function to sustain protection during chronic mycobacterial infec-
tion that cannot be compensated for by other sources of TNF, such as
myeloid cells.
Lung weights were significantly higher in T-TNF2/2 mice com-
pared to WT mice at day 150 post-infection (Fig. 5E), indicative of
enhanced inflammation. During chronic infection WT mice dis-
played discrete lesions under the pleura; while lesions appeared
coalescent and severe in T-TNF2/2 mice covering most of the lung
surface (Fig. 5F). Indeed, WT mice showed discrete granulomatous
lesions with aggregates of lymphocytes in lung tissue (Fig. 5G), while
T-TNF2/2 mice demonstrated severe pulmonary histopathology
with large necrotic areas, coalescent with no clear demarcated areas
of lymphocytic aggregates (Fig. 5G). At higher magnification the free
alveolar and airway spaces seen in WT mice were largely occluded in
T-TNF2/2 mice. Cellular degeneration was readily noticeable within
pulmonary tissue in the T-TNF2/2 mice indicating extensive nec-
rosis. Therefore, T cell derived TNF appears critical for the structural
maintenance of the granuloma during chronic M. tuberculosis infec-
tion and overall resistance to the pathogen.
Differential regulation of inflammatory genes by myeloid versus
T-cell derived TNF during acute M. tuberculosis infection. The
molecular mechanisms providing a non-redundant function of
TNF produced by T-cells and/or macrophages remain unclear.
Gene expression signatures in M. tuberculosis infected mice may
provide an insight in this respect. We assessed TNF-dependent
gene expression during M. tuberculosis infection and identified
approximately 200 genes that were up- or down-regulated in
TNF2/2 mice as compared to WT mice at 2 and 3 weeks post-
infection. Amongst these, we selected genes expressed preferen-
tially in either macrophages or T-cells, and assessed the expression
by quantitative PCR in M. tuberculosis infected M-TNF2/2 , T-
TNF2/2 or TNF2/2 mice (Fig. 6). Cytotoxic T cells signature con-
sisting of CD8a, IFNc and granzyme A as well as IFNc-induced
GTPase Irgm1/LRG47 transcription factors IRF7 or ATF3 was
abnormally high in complete TNF2/2 mice 4 weeks post M. tuber-
culosis infection, and less so in M-TNF2/2 mice, while T-TNF2/2
mice showed an intermediate phenotype (Fig. 6A), suggesting a
limited influence of T-cell derived TNF on the regulation of these
genes. Interestingly, pro-inflammatory cytokines and chemokines
such as IL-1b, IL-6, IL-17a, CXCL3 or CXCL5 or s100a9 which
were highly overexpressed in complete TNF2/2 mice 4 weeks post-
infection, were only modestly up-regulated in T-TNF2/2 mice, while
M-TNF2/2 behaved essentially like WT mice (Fig. 6B), indicating a
strong compensation of either source of TNF in this inflammatory
regulation. Acute phase protein Serum Amyloid A3 (SAA3) was
overexpressed in TNF2/2 mice and rather strongly expressed in
either T-TNF2/2- or M-TNF2/2 mice 4 weeks post-infection. The
expression of iNOS, a key anti-mycobacterial enzyme, was strongly
increased in M-TNF2/2- as well as in complete TNF2/2 mice, while
T-TNF2/2 mice had a low expression compared to infected WT mice
4 weeks post-infection. Therefore we showed that TNF derived from
either myeloid or T cells have differential effects on genes known to
contribute to the control of acute M. tuberculosis infection.
Deficiency in both myeloid- and T-cell derived TNF confers high
susceptibility to M. tuberculosis infection and reconstitutes the
phenotype of TNF2/2 mice. Our data in M. tuberculosis infected
M-TNF2/2 mice indicated a transient dependence on TNF derived
from myeloid cells to induce protection which could eventually be
compensated for by other cellular sources of TNF. T cells could
provide a compensatory cellular source of TNF and data from T-
TNF2/2 mice demonstrated the dependence on lymphocyte derived
TNF for sustained protection against chronic M. tuberculosis
infection. To investigate whether T cells were indeed the ‘‘com-
pensatory’’ cellular source of TNF essential for early control of M.
tuberculosis infection in the absence of macrophages and neutrophils
TNF, we challenged mice deficient for both myeloid- and T-cell
derived TNF (MT-TNF2/2 mice). Strikingly, MT-TNF2/2 mice
were highly susceptible to M. tuberculosis infection with rapid
bodyweight loss and death occurred within 40 days post-infection,
similar to complete TNF2/2 mice, while mice deficient for T-cell
derived TNF succumbed by day 150 and M-TNF2/2 mice survived
the duration of the experiment (Fig. 7A,B). Lung weights, an
indication of pulmonary inflammation, were markedly increased
in MT-TNF2/2 and TNF2/2 mice, and less so in T-TNF2/2 mice,
compared to M-TNF2/2 and WT mice at day 39 post-infection
(Fig. 7C). MT-TNF2/2 mice were unable to control bacterial
replication, similar to TNF2/2 mice, with a 100–1000 fold higher
pulmonary bacterial burden compared to WT control mice
(Fig. 7D). We confirmed that M-TNF2/2 and T-TNF2/2 mice had
pulmonary bacterial burdens similar to that of WT mice at 39 days
post-infection (Fig. 7D). Differences in pulmonary bacilli burden
were also visible microscopically since lung sections of MT-
TNF2/2 and TNF2/2 mice displayed widely dispersed aggregates of
acid fast bacteria that appeared to be predominantly extracellular,
while WT, M-TNF2/2 or T-TNF2/2 mice presented primarily with
single acid fast bacilli sparsely distributed in alveolar macrophages
(Fig. 7E). Enlarged, necrotic nodules characteristic of TNF2/2 mice
were also present in the lungs of MT-TNF2/2 on day 39 post infection
(Fig. 7E). Histopathologically, well defined granulomas were
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Figure 5 | T-TNF2/2 mice succumb to chronic M. tuberculosis infection. (A; B) WT (closed circle), T-TNF2/2 (grey diamond), and TNF2/2 (clear circle)
mice were infected via aerosol inhalation with 200–500 cfu/lung of M. tuberculosis H37Rv are represented (n 5 10 mice/strain). Change in bodyweight
values (A) are expressed as the mean of 4–10 mice/group. Differences in mortality rates (B) were analysed by the student’s logrank test. (C; D). The
number of viable bacteria present in lungs were assessed at 33 days (C) and 150 days (D) post-infection. The results are expressed as the mean of 4 mice/
group. (E; F and G). Lung weights (E), macroscopic lung pathology (F) and haemotoxylin and eosin staining of lung sections (G) from WT-, and
T-TNF2/2 mice infected with M. tuberculosis. Images of left lobes of WT and T-TNF2/2 mice at 150 days post infection are presented (n 5 4 mice/group).
The data is from one experiment representative of three independent experiments.
www.nature.com/scientificreports
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observed in WT mice, in contrast to both MT-TNF2/2 and TNF2/2
mice which presented with severe and necrotic lesion structures
(Fig. 7F).
Therefore, absence of TNF from both T-cells and myeloid cells
rendered mice essentially as susceptible as fully TNF-deficient mice,
demonstrating that these are the main cellular sources involved in
host control of M. tuberculosis infection. The fact that TNF produc-
tion by T-cells or by macrophages/neutrophils can partially com-
pensate each other to control of acute infection, points to some
redundant functions which may be provided by either source of TNF.
Discussion
TNF is essential for the effective control of mycobacterial infection in
several host species including humans7–9,22,27,46–48. We and others have
shown that TNF deficient mice are highly susceptible to M. bovis
BCG7,9 and M. tuberculosis6,8. Although both immune and non-
immune cells are capable of TNF synthesis, the identity of the critical
cell types contributing to immune protection remains undefined. In
this study we investigated the role of TNF from distinct cellular
sources in mediating immune protection, focusing on the contri-
bution of myeloid cells, such as macrophages and neutrophils,
and CD41/CD81 T cells in the host’s immune response against
M. tuberculosis.
Synthesis of TNF by various cell types has been demonstrated as
integral to the host’s immune response against pathogen challenge46.
Early host immune responses against M. tuberculosis infection are
characterized by leukocyte recruitment in which macrophages and
neutrophils constitute .70% of inflammatory cells47. Particularly
relevant to this study is the widely accepted paradigm that mono-
cytes/macrophages are significant sources of TNF during bacterial
infections and are therefore deemed to be critical for host resistance
to pathogens2,31,48–51. When macrophages are infected with live bacilli
or presented with either M. tuberculosis derived ligands or heat killed
bacilli in vitro, rapid production of TNF is initiated, suggesting that
they may contribute significantly to the host immune response in
vivo6. Several studies described neutrophil mediated control of M.
tuberculosis52,53 and evidence for a TNF dependent cooperative
mechanism between neutrophils and alveolar macrophages to con-
tain M. tuberculosis replication has been reported54. Furthermore,
optimum macrophage activation and mycobacterial growth inhibi-
tion are acquired through synergistic effects of TNF and IFNc pro-
duction by T cells to induce nitric oxide bactericidal mechanisms5.
Utilizing mice with highly efficient, cell lineage restricted inactiva-
tion of TNF26, we were able to show here that TNF produced by
myeloid cells has an important non-redundant function during early
control of M tuberculosis, but unexpectedly becomes redundant dur-
ing the latter stages of infection. Previous studies have shown that
virulent M tuberculosis induces TNF production by macrophages to
mediate apoptosis and escape55 whereas neutrophil-derived TNF was
reported as important for activation of macrophages54. The absence
of TNF from myeloid origin in our infection model could therefore
result in reduced activation and bactericidal capacity of infected
macrophages permitting increased bacterial replication during early
stages of infection. Interestingly, the onset of adaptive immune
Figure 6 | Inflammatory gene expression during acute M. tuberculosis infection in cell-specific TNF2/2 mice. (A; B) Analysis of selected inflammatory
gene expression was performed by quantitative RT-PCR on day 28 after M. tuberculosis infection and normalized to b-actin. (n 5 3–4 mice per point).
Genes include CD8a, IFNc, granzyme A,Irgm1/LRG47, IRF7 and ATF3 (Fig. 6A), the proinflammatory cytokines and chemokines IL-1b, IL-6, IL-17a,
CXCL3 or CXCL5 and s100a9, the acute phase reactant, SAA and iNOS (Fig. 6B).
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Figure 7 | MT-TNF2/2 mice are highly susceptible and succumb to acute M. tuberculosis infection. (A; B) WT (closed circle), M-TNF2/2
(grey triangle), T-TNF2/2 (grey diamond), MT-TNF2/2 mice (clear square) and TNF2/2 (clear circle) mice infected as described were monitored for
change in bodyweight (A; expressed as the mean of 4–10 mice/group) and survival (B; n 5 10 mice/group) Data is from one experiment representative of
three independent experiments. (C; D) The lung weights (C) and number of viable bacteria present in lungs (D) were assessed at 39 days post-infection.
The results are expressed as the mean 6 SD of 4–5 mice/group and are from one experiment, representative of two independent experiments.
(E; F) Pulmonary bacilli burdens on day 39 were confirmed by Ziehl-Neelsen staining (E; magnification 6003). Arrows indicate the presence of single
AFB within macrophages. Images of left lobes illustrating macroscopic pulmonary pathology in WT-, M-TNF2/2, T-TNF2/2, MT-TNF2/2 and TNF2/2
mice. (n 5 5 mice/group). Images are representative of one of three independent experiments. Haemotoxylin and eosin staining show enlarged, necrotic
nodules in the lungs of MT-TNF2/2 and TNF2/2 mice at day 39 post infection (F). Images are representative of one of three independent experiments.
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responses coincided with a reduction in bacterial growth eventually
resulting in burden equivalent to WT control mice. From previous
studies it was concluded that the recruitment of effector antigen
specific CD41- and CD81 T cells is critical to further enhance
infected macrophage killing capacity at the site of infection and the
subsequent killing of the intracellular bacilli56,57. Our data show that
in the absence of TNF from macrophages and neutrophils M-
TNF2/2 mice have enhanced pulmonary effector CD41- and CD81
T cell recruitment during early infection. While the increased recruit-
ment was associated with increased bacterial burden elevated num-
bers of T cells likely contributed with TNF production to compensate
the lack of macrophage/neutrophil-derived TNF. Susceptibility in
M-TNF2/2 mice was therefore not due to the lack of T cells at local
sites of infection, unlike the situation in complete TNF2/2 mice
where CD41- and CD81 T cell recruitment was initially delayed,
but became unregulated during terminal stages of infection.
Rather, this increased influx of CD41- and CD81 T cells early on
in M-TNF2/2 mice points to an important function of TNF produced
by macrophages and neutrophils in the regulation of CD41- and
CD81 T cell recruitment. Nonetheless, we postulated that although
T cell recruitment was not impaired in M-TNF2/2 mice, the effector
function of recruited cells may have been compromised. Our data
demonstrated that recruited CD41- and CD81 T cells were fully
mature effector cells, expressing CD44 and CD69 activation markers.
Moreover these lymphocytes were primed against M. tuberculosis
and hence could potentially initiate macrophage bactericidal
mechanisms. Previous studies have shown that Th1 immune func-
tion is mediated predominantly by M. tuberculosis antigen specific
IFNc expression by CD41- and CD81 T cells that can upregulate the
antimycobacterial function of macrophages at the site of infection40.
These primed pulmonary CD41- and CD81T cells of M-TNF2/2
mice were also capable of synthesising TNF and IFNc which resulted
in the induction of nitric oxide synthesis in M. tuberculosis infected
macrophages43,58,59. We therefore postulated that key to the eventual
resistance to M. tuberculosis infection of M-TNF2/2 mice was the
potential substitution of TNF produced by myeloid cells with TNF
from recruited activated T cells resulting in an effective and protect-
ive adaptive immune response.
Indeed, the transient nature of disease susceptibility in M-TNF2/2
mice indicated that compensatory mechanisms and other cellular
sources of TNF allowed for the eventual establishment of full pro-
tective immunity. Several studies highlighted T cells as sources of
TNF that impacted on disease outcome during bacterial chal-
lenge60,61. T cell derived TNF in association with GM-CSF induce
macrophage aggregation that may contribute to the formation of
granulomas during host immune protective responses against myco-
bacterial infection61. Furthermore, a modest increase in resistance of
M. tuberculosis infected RAG2/2 and TNF2/2 mice after transfer of T
cells capable of producing TNF was reported25. Adoptive transfer
approaches have inherent limitations and did not allow for direct
interrogation of the role of T cell derived TNF. Here we used a loss of
function approach through the use of T cell specific deletion of TNF
gene in both CD41 and CD81 T cells which has distinct advantages
over the adoptive transfer approach, especially for long-term studies
of chronic infection studies. Previous reports documented distinct
and non-redundant functions of TNF produced by T cells, macro-
phages and neutrophils for primary defence against Listeria mono-
cytogenes whereas T cell derived TNF appeared subservient in
function26. Our present findings support a clear and distinctive
non-redundant function for TNF derived from T cells during per-
sistent infection, which may be dispensable during initial immune
responses. Interestingly, mortality in T-TNF2/2 mice was associated
with a relatively modest increase in bacterial burden compared to
WT mice, as opposed to TNF2/2 mice which succumbed with sig-
nificantly higher bacilli burdens. However, moribund T-TNF2/2
mice presented with an aggressive pulmonary pathology, indicating
that T cell derived TNF is required primarily for down regulation of
inflammation during persistent/chronic M. tuberculosis infection
rather than for bactericidal mechanisms. Increased susceptibility
and eventual mortality of TNF2/2 mice may thus be a consequence
of pulmonary pathology induced by an unregulated immune res-
ponse. Increased recruitment of CD41 and CD81 T cells have prev-
iously been reported by Zganiacz et al, where the authors elegantly
illustrated the regulatory function of TNF mediated through both
TNFRp55 and TNFRp7562. Neutralisation of TNF led to disregulated
pulmonary pathology accompanied by enhanced production of spe-
cific proinflammatory cytokines responsible for the control and
migration of different leukocytes including macrophages and T cells.
Although the presence of TNF produced by macrophages and/or
other cell types within the granulomatous structures in T-TNF2/2
mice were able to contain early mycobacterial infection, the absence
of TNF production by T cells during chronic infection resulted in
inefficient recruitment of effector T cells, leading to inefficient TNF
dependent signalling within the microenvironment of the granu-
loma. Here, we convincingly demonstrated dependence on CD41-
and/or CD81T cell derived TNF for sustaining structural and
functional integrity of granulomas during chronic infection, in spite
of the fact that it was not required for its initial establishment. Egen
et al., 2008 have elegantly shown that effector T cells are rapidly
recruited to existing granulomas and are retained within these struc-
tures with limited egress from lesions60. The authors further demon-
strated that T cells within granulomas are highly motile, actively
interacting with resident macrophages and apparently provided sig-
nals essential for the maintenance of granuloma structure. Anti-TNF
treatment both inhibited recruitment of effector T cells to granulo-
mas and restricted movement of T cells within granulomas. It is
therefore interesting to speculate on the contribution of TNF pro-
duced by T cells in providing T cell-macrophage interaction for the
maintenance of structural granuloma integrity. The lack of structural
granuloma integrity in T-TNF2/2 mice would argue strongly for an
essential role of T cell derived TNF, possibly in its membrane-bound
form, in driving T cell-macrophages interaction during structural
granuloma formation. In fact, we and others showed earlier that
not only soluble TNF but also membrane-bound TNF is important
for the control of M. tuberculosis infection17,19. Thus, local, cell-
associated TNF interactions are likely important for the multi-fold
effects of TNF, and measuring soluble TNF in the lung might not give
the full picture. This was also documented in an earlier study using
TNF expressing BCG, where a limited, local production of TNF at the
site of infection conferred protection against M. bovis BCG in TNF-
deficient mice63. We report low levels of TNF expression in wild-type,
M-TNF2/2 or T-TNF2/2 mice. Indeed, it is our experience that the
pulmonary protein concentration of soluble TNF remains low, even
after 1–3 months of M. tuberculosis infection, as compared to other
pro-inflammatory cytokines/chemokines such as IL-1, MCP1 or
RANTES which are more up-regulated and reach levels in the ng/
lung range64,65).
The initial establishment of granuloma to facilitate myeloid-T cell
interaction is significantly dependent on controlled cellular inflam-
mation in response to infection. Th1 polarisation of the adaptive
response to M. tuberculosis infection has been illustrated at the tran-
scriptional level by persistent induction of CD8a, IFNc and gran-
zyme A transcripts 15–100 days post-infection66,67. Here, we show
that in complete absence of TNF there was a very high induction of
molecules indicative of cytotoxic T-cell signature such as CD8a,
IFNc and granzyme A, of ATF3, a positive regulator of IFNc express-
ion68, of IFNc-induced GTPase irgm1/LRG47 and IFNc signalling
pathway IRF7, 4 weeks post M. tuberculosis infection, as compared
with wild-type mice. The over-induction of these genes was similar
or only slightly less marked in mice deficient for T-cell derived TNF,
indicating that TNF from T-cell origin is dispensable for this up-
regulation. However, the over-induction of cytotoxic T cell signature
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genes was more limited in M-TNF2/2 mice, indicating that TNF
from myeloid origin is essential for the up-regulation of these genes.
A strong and persistent inflammatory response was documented as
early as 2–3 weeks post M. tuberculosis infection, by the transcrip-
tional up-regulation of pro-inflammatory cytokines including TNF
itself, IL-1b or IL-6, of chemokines such as CXCL5, but also of acute
response proteins such as SAA3 or S100a9, and of iNOS, a key anti-
mycobacterial enzyme source of reactive nitrogen66,67. We show that
the inflammatory signature was strongly increased in complete TNF-
deficient mice 4 weeks post M. tuberculosis infection, which may
result from the very high infectious burden in these mice at this time
point. Interestingly, IL-1b, IL-6, IL-17a, CXCL3, CXCL5 or S100a9
were much less up-regulated in T-TNF2/2 mice, and M-TNF2/2
behaved essentially like WT mice. iNOS was strongly over-expressed
in mice fully deficient for TNF or in M-TNF2/2 mice, while T-
TNF2/2 mice had a low expression, as compared to infected WT
mice. Thus, TNF per se is dispensable for the induction of these
inflammatory mediators and might be compensated for by other
up-regulated inflammatory cytokines. The data correlates with the
phenotypic profiles of the respective strains and supports the relative
importance and differential effects of TNF produced by macrophages
and T cells in the control of acute M. tuberculosis infection.
The similarity in phenotype between WT and T-TNF2/2 mice
together with the disparate phenotypes between WT and M-
TNF2/2 mice during acute M. tuberculosis infection indicated that
TNF produced by myeloid cells is more relevant for early host
immune defence as compared to T cell derived TNF. Nonetheless,
we hypothesised that recruited T cells capable of TNF synthesis could
contribute to rescue M. tuberculosis infected M-TNF2/2 mice from
early defect in resistance to infection. We therefore characterized
host immune function against M. tuberculosis in MT-TNF mice, in
which case macrophages/neutrophils, and T cells were incapable of
TNF synthesis. We argued that deletion of TNF synthesis capability
from CD41- and CD81 T cells in M-TNF2/2 mice would render the
host unable to draw on the secondary TNF cellular source to induce
immune protection. The extent of susceptibility of M. tuberculosis
infected MT-TNF2/2 mice was indistinguishable from TNF2/2 mice
indicating that macrophage/neutrophils and T cells are the main
cellular sources of TNF required to generate complete protection
against M. tuberculosis infection. Combined TNF deficiency in mye-
loid cells and T cells resulted in exacerbated disease progression with
uncontrolled bacterial growth in organs and severe pulmonary
pathology and mortality, clearly pointing out to redundant essential
functions of TNF from these distinct cellular sources.
In conclusion, this study provides significant insights on TNF
cellular source requirements for host immune responses against M.
tuberculosis challenge. Although widely acclaimed as the major cel-
lular source of TNF, macrophages have a surprisingly limited role in
restricting bacterial replication through TNF dependent synthesis
during M. tuberculosis infection. Disease outcome resides rather with
T cell derived TNF whose function appears as non-redundant. Our
data imply that inhibiting TNF synthesis in T cells during latent M.
tuberculosis infection may lead to an imbalance in the cytokine pro-
file within the granuloma microenvironment with subsequent poten-
tial for reactivation and immunopathology. TNF neutralizing
therapies used in severe inflammatory diseases should thus spare
T-cell derived TNF and this may reduce the risk of tuberculosis
reactivation. We clearly demonstrated the existence of labour divi-
sion between myeloid cells and T cells in provision of protective TNF
which implicates both redundant and non-redundant functions of
this cytokine from distinct cellular sources.
Methods
Mice. All animal strains used in this study were previously described26. TNF ‘‘floxed’’
(WT control) mice were crossed with MLys-Cre deleter mice to generate myeloid,
macrophage/neutrophil TNF deficient mice (M-TNF2/2) and similarly crossed with
CD4-Cre deleter mice to generate T-cell TNF deficient mice (T-TNF2/2). M-TNF2/2
and T-TNF mice were in turn intercrossed to generate TNF ablation in both myeloid
cells and T cells (MT-TNF2/2). In addition, complete TNF deficient (TNF2/2) mice
were used as controls. Animals were bred under specific pathogen free conditions at
the University of Cape Town or Transgenic institute (CNRS UPS44, Orleans, France)
and used between 6–12 weeks. Infected animals were maintained in individually
ventilated cages or isolators under biosafety level 3 conditions.
Ethics statement. All animal experimental protocols complied with South African or
French regulations. Approval was obtained from the Animal Research Ethics
Committee, University of Cape Town, South Africa in accordance with the South
African National Standard 10386-The care and use of animals for scientific purposes or
were approved by the ‘‘Ethics Committee for Animal Experimentation of CNRS
Campus Orleans’’ (CCO), registered (Nu3) by the French National Committee of
Ethical Reflexion for Animal Experimentation, under the Nu CLE CCO 2011-029 in
compliance with the French ethical and animal experiments regulations (see Charte
Nationale, Code Rural R 214–122, 124).
Mycobacteria and infection. Mycobacterium tuberculosis H37Rv was grown in Difco
Middlebrook 7H9 medium containing 0.5% glycerol and enriched with 10% OADC.
Cultures were incubated at 37uC and grown until log phase, aliquoted and maintained
as frozen stocks at 270uC. An aliquot of M. tuberculosis H37Rv was rapidly thawed at
37uC, passed 303 through a 29.5G needle and diluted in sterile saline. Mice were
infected at doses of 200–500 cfu/lung using a Glas-Col Inhalation Exposure System
Model A4224. The pulmonary infection dose was confirmed by sacrificing 10 mice 1
day after infection and plating the homogenised lung tissue on Difco Middlebrook
7H10 agar plates in 10 fold serial dilutions. Plates were semi-sealed in plastic bags,
incubated for 17–21 days at 37uC and the number of mycobacterial colonies was
counted.
Single cell preparation, cell restimulation, intracellular cytokine staining and
analysis by flow cytometry. Lungs were perfused by injecting 5 ml of cold PBS
containing 20 U/ml heparin in the right ventricle of the heart. Lungs were removed,
sectioned on ice and incubated in PBS containing 50 U/ml collagenase I
(Worthington Biomedical Corporation, Lakewood, NJ) and 13 ug/ml DNAse I
(Boehringer-Mannheim, Germany) at 37uC for 90 minutes. For single cell
suspensions lung tissue was passed through a 70 mm nylon cell strainer
(Beckton and Dickinson), washed 23 with PBS and the cell concentration
determined by counting in the presence of trypan blue. Cells were labelled using the
following antibodies: anti-mouse CD3 (Clone 17A2; Pharmingen); anti-mouse CD8a
(Clone 53–6.7; Pharmingen); anti-mouse CD4 (Clone RM4-5; Pharmingen),
anti-mouse CD44 mouse (Clone IM7; Pharmingen) and anti-mouse CD69 (Clone
H1.2F3; Pharmingen). 1 3 106 cells were incubated for 20 minutes with anti-CD16/
32 (Clone 2.4G2; Pharmingen) to block Fc receptors in 96 well round bottom plates
(Sterilin). Cells were washed with PBS/0.1% BSA/0.01% NaN3 and incubated with
2 ug/ml of appropriate antibodies for 20 minutes in the dark. Excess antibodies were
removed by washing cells 23 with PBS/0.1% BSA/0.01% NaN3, then pelleted cells
were fixed for 18–24 hours in 10% PBS buffered formalin.
For intracellular staining, single cell suspensions of lungs were restimulated with
plate-bound anti-mouse CD3 (5 mg/ml;clone 145-2c11) and anti-mouse CD28
(5 mg/ml; clone 37.51), ESAT-6 (10 mg/ml; Staten Serum Institute) and PPD
(10 mg/ml; Staten Serum Institute) for 6 hours in the presence of Brefeldin A
(5 mg/ml). Cells were labelled with either anti-mouse CD8a (Clone 53–6.7;
Pharmingen) or anti-mouse CD4 (Clone RM4-5; Pharmingen) and anti-mouse
IFNc (Clone XMG1.2; Pharmingen). Analysis was done using FACScalibur
(Beckton and Dickinson) incorporating Cellquest software.
For cytokine measurements samples were subjected to ELISA using antibody
and protein standards obtained from RnD Systems Inc.,(Minneapolis, MN).
Absorbance was measured using a Versamax Microplate Reader (Molecular Devices,
LLC, CA)
Lung morphology. Lungs were fixed in phosphate buffered formalin and embedded
in paraffin wax. Tissues were sectioned at 2 mm, stained with hematoxylin and eosin
and Ziehl-Neelsen, and subsequently mounted with Canada balsam. Images of
stained tissue sections were captured using an Olympus E330 digital camera attached
to Olympus Model BX40F microscope. Macroscopic lung images were captured with
Pentax Optio M40 camera.
Analysis of mRNA gene expression. Total RNA were isolated from lungs by
TRIzol reagent (Sigma, St. Louis,MO) and purified by RNeasy Mini Kit (Qiagen,
Valencia, CA) at the indicated times after M. tuberculosis infection. For quantitative
RT-PCR 1 ug of total RNA was pretreated by DNaseI and converted to cDNA by
ImProm-IITM Reverse Transcriptase (Promega, Madison, WI) using random
nonamer primers. Q-PCR reactions were performed using Brillant II SYBR
QPCR kits and a Stratagene Mx3005P thermocycler (Agilent, Palo Alto, CA).
The following program was used: 95uC for 15 min and 40 cycles 95uC for 10 sec and
60uC for 30 sec. Primers used for quantitative PCR are provided in Supplementary
Table 1.
Statistical analysis. Statistical analysis was performed by ANOVA or the Student’s t
test. For mortality studies, analysis was performed using the logrank test. For all tests,
a p value of ,0.05 was considered significant.
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